Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1). Both endocannabinoids and TRPA1 may modulate gastrointestinal motility.
More Information Supplier PageCannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1). Both endocannabinoids and TRPA1 may modulate gastrointestinal motility.
More Information Supplier PageLinoleylethanolamide is an endocannabinoid that also binds to TRPV1 (Ki = 5.60 ??M).
More Information Supplier PageLinoleylethanolamide is an endocannabinoid that also binds to TRPV1 (Ki = 5.60 ??M).
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageYM90K hydrochloride is a selective AMPA receptor antagonist that delays neuronal death in a global ischemia model and cerebral infarction in a focal ischemia model following postischemic administration.
More Information Supplier PageLM22A-4 is a potent tropomyosin-related kinase B (TrkB) agonist (IC50 = 47 nM).
More Information Supplier PageLM22A-4 is a potent tropomyosin-related kinase B (TrkB) agonist (IC50 = 47 nM).
More Information Supplier PageSB 218078 is an inhibitor of checkpoint kinase 1 (Chk1) that displays selectivity over other protein kinases (IC50 values are 15, 250 and 1000 nM for Chk1, cdc2 and PKC respectively)
More Information Supplier Page
